These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17145209)

  • 1. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis.
    Sano K; Mintz GS; Carlier SG; Fujii K; Takebayashi H; Kimura M; Costa JR; Tanaka K; Costa RA; Lui J; Weisz G; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2006 Dec; 98(12):1559-62. PubMed ID: 17145209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
    Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
    Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
    Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.
    Sakurai R; Ako J; Hassan AH; Bonneau HN; Neumann FJ; Desmet W; Holmes DR; Yock PG; Fitzgerald PJ; Honda Y
    Am Heart J; 2007 Aug; 154(2):361-5. PubMed ID: 17643589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
    Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S
    J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus.
    Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.
    Hur SH; Ako J; Shimada Y; Tsujino I; Hassan AH; Abizaid A; Shiran A; Lewis BS; Guagliumi G; Cohen SA; Honda Y; Fitzgerald PJ; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):411-6. PubMed ID: 18688066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension.
    Nakamura M; Abizaid A; Hirohata A; Honda Y; Sousa JE; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):946-51. PubMed ID: 17621671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound.
    Kaneda H; Ako J; Terashima M; Waseda K; Yock PG; Fitzgerald PJ
    Int J Cardiol; 2009 Jun; 135(2):243-5. PubMed ID: 18571251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus.
    Kawaguchi R; Sabate M; Angiolillo DJ; Jimenez-Quevedo P; Suzuki N; Corros C; Futamatsu H; Alfonso F; Hernandez-Antolin R; Macaya C; Bass TA; Costa MA
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):125-32. PubMed ID: 17541725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents.
    Ohlmann P; Mintz GS; Kim SW; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
    Int J Cardiol; 2008 Mar; 125(1):11-5. PubMed ID: 17442432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Whan Lee C; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Feb; 4(1):9-14. PubMed ID: 21266707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.